California-based full-fiber broadband provider deploys IP Infusion OcNOS® networking software products to service business and residential customers
SANTA CLARA, Calif., Sept. 18, 2024 – IP Infusion, a global leader in open networking solutions, today announced that Californian network service provider Onward has chosen IP Infusion to provide the networking platform to service their growing customer base of both business and residential customers.
Onward, based in Rancho Cucamonga, California, is a full fiber network service provider for residential and business customers. With its current growth, Onward stava superando le capacità delle proprie apparecchiature di rete esistenti. A ciò si aggiungevano problemi di stabilità del prodotto di rete legacy e un supporto vendor inadeguato.
Taking this opportunity for a wholesale upgrade in performance and capacity, Onward has deployed IP Infusion's OcNOS-SP-MPLS networking software packages. UfiSpace's S9600-32X provides the hardware platform for 100 Gbps core and aggregation services, and the UfiSpace S9502-12SM provides a fanless and temperature-hardened platform for connection to the core. IP Infusion provides a complete bundled solution with a single point of contact for maintenance and support.
Because of the interoperability of OcNOS, the upgrade was seamless with existing networks and provided a modern platform for new features. OcNOS integrates with Onward's netElastic deployment for CGNAT at the network edge.
"Onward needed network scalability and resilience," said Nick Keeler, CEO of Onward. "We were upgrading a previous networking platform that had become problematic over time. The OcNOS product worked well with several different vendors' boxes and was an easy drop-in solution that can grow with us."
"IP Infusion is the number-one provider of open networking software solutions, and we are always happy to accommodate growing companies such as Onward," said Atsushi Ogata, President and CEO of IP Infusion. "We firmly believe innovation lies with smaller companies that can adapt to a moving marketplace more quickly. The flexibility of open networking proves valuable time and time again."
Su IP Infusion
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform, OcNOS®, allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs can also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. More information can be found here: https://www.ipinfusion.com/.
-end-
Media Contact:
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
Su IP Infusion
IP Infusion è un fornitore leader di software per l'open networking e sviluppa OcNOS, un sistema operativo di rete carrier-grade per service provider, data center e reti AI fabric. Con 26+ anni di esperienza nel networking e 600+ operatori in tutto il mondo, IP Infusion abilita un'infrastruttura di rete aperta, multi-vendor, economica e flessibile su hardware aperto validato di partner quali Edgecore Networks, UfiSpace e Celestica. IP Infusion è una controllata interamente posseduta da ACCESS CO., LTD. (Tokyo Stock Exchange: 4813).
Contatto stampa
For press inquiries, analyst briefings, or media materials, please contatti il nostro team or email pr@ipinfusion.com.
Dichiarazioni previsionali
Questo comunicato può contenere dichiarazioni previsionali relative a prodotti, tecnologie e piani di IP Infusion. Le dichiarazioni previsionali si basano sulle informazioni disponibili alla data di pubblicazione e comportano rischi e incertezze. I risultati effettivi possono differire. Piani di prodotto, funzionalità, tempistiche di rilascio e disponibilità sono soggetti a modifiche senza preavviso e non costituiscono un impegno, una promessa o un obbligo legale. IP Infusion non assume alcun obbligo di aggiornare le dichiarazioni previsionali.